To honor her 11-year “cancerversary,” Ivana Mihajlovic, a 41-year-old peritoneal mesothelioma warrior, is hosting a Fundraise for Meso event on Saturday, Nov. 21 in Kensington,…
Arkadiusz Dudek, MD, PhD, discusses the Phase 2 Nivolumab (Opdivo) + Ramucirumab clinical trial for previously-treated mesothelioma patients. The study is available at Moffitt Cancer…